Literature DB >> 15036828

Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men.

Noriyuki Nakanishi1, Toshio Takatorige, Hideki Fukuda, Kokoro Shirai, Wenjuan Li, Mitsuharu Okamoto, Hiroshi Yoshida, Yoshio Matsuo, Kenji Suzuki, Kozo Tatara.   

Abstract

To determine whether the clustered features of the metabolic syndrome precede the 7 year incidence of cardiovascular disease (CVD) and type 2 diabetes, we examined 6182 Japanese male office workers aged 35-59 years without any history of CVD. The 5588 subjects without type 2 diabetes also constituted the nondiabetic cohort, and were re-examined over seven successive years. Components of the metabolic syndrome included glycemic disorder (type 2 diabetes for the risk of CVD and impaired fasting glucose for the risk of type 2 diabetes), systemic obesity, hypertension, dyslipidemia, proteinuria, and elevated white blood cell (WBC) count. After controlling for age, family history of diabetes, alcohol intake, and cigarette smoking, the multivariate-adjusted relative risk of incidence of CVD compared with absence of components was 3.18, 3.48, 12.55, and 14.15 (P for trend <0.001), for the presence of 1,2,3, and > or =4 components, respectively. The corresponding relative risks of incidence of type 2 diabetes were 1.92, 4.36, 6.44, and 15.08 (P for trend <0.001). In both non-smokers and current smokers, the multivariate-adjusted relative risks of incidence of CVD and type 2 diabetes increased as the number of components increased (P for trend <0.001 for all). Our findings indicate that clustered features of the metabolic syndrome are closely associated with development of CVD and type 2 diabetes in middle-aged Japanese.

Entities:  

Mesh:

Year:  2004        PMID: 15036828     DOI: 10.1016/j.diabres.2003.10.001

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  18 in total

1.  Principal component 1 score calculated from metabolic syndrome diagnostic parameters is a possible marker for the development of metabolic syndrome in middle-aged Japanese men without treatment for metabolic diseases.

Authors:  Kazuki Mochizuki; Rie Miyauchi; Yasumi Misaki; Yoko Ichikawa; Toshinao Goda
Journal:  Eur J Nutr       Date:  2011-12-09       Impact factor: 5.614

2.  Association Between Elevated Liver Enzymes and Metabolic Syndrome Among Thai Adults.

Authors:  Sajithya Perera; Vitool Lohsoonthorn; Wiroj Jiamjarasrangsi; Somrat Lertmaharit; Michelle A Williams
Journal:  Diabetes Metab Syndr       Date:  2008-09

3.  Low rates of exercise in patients with metabolic syndrome after an acute coronary syndrome.

Authors:  Hussam Abuissa; Avinash Khanna; John Spertus
Journal:  Clin Cardiol       Date:  2005-11       Impact factor: 2.882

4.  Linkage of epidemiologic evidence with the clinical aspects of metabolic syndrome.

Authors:  Sun Ha Jee; Jaeseong Jo
Journal:  Korean Circ J       Date:  2012-06-28       Impact factor: 3.243

5.  Inverse association between central obesity and arterial stiffness in Korean subjects with metabolic syndrome: a cross-sectional cohort study.

Authors:  Ki-Bum Won; Hyuk-Jae Chang; Hiroyuki Niinuma; Koichiro Niwa; Kyewon Jeon; In-Jeong Cho; Chi-Young Shim; Geu-Ru Hong; Namsik Chung
Journal:  Diabetol Metab Syndr       Date:  2015-01-27       Impact factor: 3.320

6.  Impact of metabolic syndrome compared with impaired fasting glucose on the development of type 2 diabetes in a general Japanese population: the Hisayama study.

Authors:  Naoko Mukai; Yasufumi Doi; Toshiharu Ninomiya; Jun Hata; Koji Yonemoto; Masanori Iwase; Mitsuo Iida; Yutaka Kiyohara
Journal:  Diabetes Care       Date:  2009-09-03       Impact factor: 17.152

Review 7.  Antihypertensive therapy, new-onset diabetes, and cardiovascular disease.

Authors:  J N Basile
Journal:  Int J Clin Pract       Date:  2009-02-09       Impact factor: 2.503

8.  Differences in the prevalence of metabolic syndrome in boys and girls based on various definitions.

Authors:  Nizal Sarrafzadegan; Mojgan Gharipour; Masoumeh Sadeghi; Fatemeh Nouri; Sedigheh Asgary; Sonia Zarfeshani
Journal:  ARYA Atheroscler       Date:  2013-01

9.  Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes.

Authors:  Ki-Bum Won; Hyuk-Jae Chang; Hyeon-Chang Kim; Kyewon Jeon; Hancheol Lee; Sanghoon Shin; In-Jeong Cho; Sung-Ha Park; Sang-Hak Lee; Yangsoo Jang
Journal:  Cardiovasc Diabetol       Date:  2013-03-04       Impact factor: 9.951

10.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.